CORPORATE KEY INDIVIDUALS
Edward Hlozek, CEO and Chairman
Most recently CEO of Mind & Associates, Inc., Edward has been a senior level business executive and founder and Director of interventional and surgical medical minimally invasive companies in cardiac, neurologic, orthopedic, urologic, gynecologic and ENT. Financial and clinical introductory oversight for Class I, II & III Devices for minimally invasive techniques in all surgical specialties, including RF therapy devices.
Richard Heuser, MD, FACC, FACP,
Internationally-recognized cardiologist, inventor, educator, author and one of the early pioneers of the angioplasty procedure. Author of over 180 research studies, and holder of over 50 patents. Scientific Advisory Board Chair for ValveCure, and Chief of Cardiology at St. Lukes, Phoenix.
Tom Witzel, VP Operations
Tom has extensive experience managing and participating in pre-clinical procedures and studies. Working with leading cardiovascular technologies, including heart valves and other surgical and endovascular devices, Tom has collaborated with prominent cardiovascular physicians in the U.S., Europe, and China. As an employee and consultant, Tom has completed pre-clinical projects for Edwards Lifesciences, Ventrica, HeartPort, MiCardia, and 3F Therapeutics.
John Osth, CFO
CEO of NanoSomix, previously CEO Celula, Inc., Chairman & CEO of QuantumCor Inc., of which he has been a founder. He John has also held senior level positions at Baxter Healthcare including President of the Immunotherapy Division and head of European R&D.
Board of Directors
- Edward Hlozek, Chairman
- Richard Heuser, MD, SAB Chairman
- John Osth
- Thomas Witzel
Scientific Advisory Board
- Richard Heuser, MD
- David Adams, MD
- Peter Block, MD
- Randy Chitwood, MD
- Saibal Kar, MD
- Jeffrey Milliken, MD